Monday, November 9, 2026

EUR/CHF Over 1% Down In The Last 21 Sessions

EUR/CHF Over 1% Down In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.85% for the last 21 sessions. At 09:07 EST on Tuesday, 25 July, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 1.686% up from its 52-week low and 5.041% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.11%, and a positive 0.22%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.23% (last week), 0.20% (last month), and 0.22% (last quarter), respectively.

News about

  • Usd/jpy May turn lower in the event boj surprises on Friday – OCBC. According to FXStreet on Monday, 24 July, "In the event BoJ surprises on Friday, then we may see USD/JPY turn lower as markets may be caught wrongfooted."
  • Usd/jpy pulls back from two-week high, trades with modest losses below mid-141.00s. According to FXStreet on Monday, 24 July, "This revives hopes that the BoJ might tweak its Yield Curve Control (YCC) policy later this week, which, along with a softer risk tone, underpins the safe-haven JPY and act as a headwind for the USD/JPY pair.", "Apart from this, the broader risk sentiment might also contribute to producing short-term opportunities around the USD/JPY pair."
  • Usd/jpy consolidates above the 141.40 area, investors await the US CB consumer confidence. According to FXStreet on Tuesday, 25 July, "The monetary policy divergence between the BoJ and Fed might exert pressure on the Japanese Yen against its major rivals and could be a headwind for the USD/JPY pair. ", "Traders will take cues from the data and find opportunities around the USD/JPY pair."
  • Usd/jpy technical analysis: central bank policies determine the fate - 24 July 2023. According to DailyForex on Monday, 24 July, "According to the fundamental analysis, the USD/JPY currency pair is trading affected by the results of the recent economic data, as the Japanese National Consumer Price Index for June missed the expected change (yearly) by 3.5% with a change of 3.3%. ", "Last Thursday, US initial jobless claims for the week ending July 14 exceeded the expected claims count of 245,000 with a count of 228,000, while continuing claims for the prior period topped 1.729 million with a claims count of 1.754 million.USD/JPY Technical OutlookThe price of the USD/JPY currency pair has now advanced to trade a few levels above the 100-hour moving average line. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com